Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...

Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

By Marleen Kaesebier BASEL, Switzerland, May 5 (Reuters) - Switzerland's biotech industry shifted toward private financing in 2025 as funding from capital markets remained difficult to obtain and ...

Artificial intelligence has dominated investor attention for two years, but biotech revenue lines are also bending sharply ...

New coalition forms to develop a national innovation roadmap to strengthen and extend America’s global leadership in biotechnologyWASHINGTON--(BUSINESS WIRE)--The American Biotech Innovation Alliance ...

Biopharma is rebounding across rare disease, oncology and neuroscience. Here, Cytokinetics achieved a rare milestone: a first ...

If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily S&P Biotech Bull 3X Shares ...

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, ...